AzTrials
AzTrials

All Health Backgrounds to Determine a Baseline of Flatus ActivityNCT07134543

Using the Smart Underwear Device to Determine a Baseline of Flatus Activity Normalized to Fiber Intake

An observational study of All Health Backgrounds to Determine a Baseline of Flatus Activity, run by University of Maryland, College Park at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to quantify the typical frequency of flatulence in healthy adults, normalized by fiber intake, using the Smart Underwear device. The study will enroll a maximum of 500 adults across the United States who will wear the device for three consecutive days while continuing their… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
500 participants
Where
2 sitesUnited States
Study dates
1 Dec 2025to 1 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Residents of the US

Who may be able to join

  • 18 years old or older
  • Lives in the US
  • Is not pregnant or lactating
  • Is willing to wear the Smart Underwear device as instructed in the study procedures

Who cannot join

  • Younger than 18 years old
  • Lives outside the US
  • Is pregnant or lactating
  • Is not willing to wear the Smart Underwear device as instructed in the study procedures

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Brantley Hall, PhD contact

5407978040

brantley@umd.edu

United States2 sites, 2 recruiting
  • Bioscience Research Building

    College Park, Maryland, 20742

    Brantley Hall, PhD, 540-797-8040, brantley@umd.edu

    Not yet recruiting
  • University of Maryland Bioscience Research Building

    College Park, Maryland, 20742

    Branley Hall, PhD, 301-405-7481, brantley@umd.edu

    Recruiting

Other trials in United States

About this study

The goal of this observational study is to quantify the typical frequency of flatulence in healthy adults, normalized by fiber intake, using the Smart Underwear device. The study will enroll a maximum of 500 adults across the United States who will wear the device for three consecutive days while continuing their usual daily activities.

The main questions it aims to answer are:

Read more
  • What is the average frequency of flatus events in a general adult population?
  • How does dietary fiber intake influence flatus frequency and microbiome activity?

Researchers will collect gas sensor data from the Smart Underwear device alongside dietary information logged in a mobile app to assess the relationship between diet and microbiome activity.

Participants will:

  • Complete an online eligibility survey, consent form, and background questionnaire.
  • Wear the Smart Underwear device for at least 12 hours per day for three consecutive days.
  • Log all meals with photos using a custom smartphone app.
  • Complete a short post-wear survey about device comfort and usability.

All study procedures will be conducted remotely. Data will be analyzed in de-identified form to evaluate baseline flatulence patterns, normalized to fiber intake, in the general adult population.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07134543
Study groupRoleWhat they receive
American adultsAmerican adults that are at least 18 years old, live in the United States, are not pregnant or lactating, and agree to wear the Smart Underwear device.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Microbiome Activity Index

    The Microbiome Activity Index is a composite measure reflecting gut microbiome activity, calculated from both flatus frequency and hydrogen gas concentration. The index uses the absolute value of the first derivative of the hydrogen sensor signal to better capture flatus intensity, reduce baseline noise, and mitigate sensor saturation at high hydrogen levels. This composite approach ensures a more accurate representation of gut microbiome activity than relying on flatus count or hydrogen concentration alone. Data are collected using a wearable device ("Smart Underwear") and uploaded to the Human Flatus Atlas app.

    Measured: 12 hours each day for 3 days

Secondary outcomes (4)
  1. Total flatus count

    The total number of flatus events detected by the wearable device. Detection is based on hydrogen gas concentration changes and signal rate-of-change analysis.

    Measured: 12 hours each day for 3 days

  2. Flatus Per Hour

    The rate of flatus events normalized per hour, calculated from the total number of events and the total monitored time.

    Measured: 12 hours each day for 3 days

  3. Microbiome Activity Index Comparative Score

    A relative score comparing the participant's Microbiome Activity Index to aggregated anonymized results from other individuals in the Human Flatus Atlas study. Presented as a percentile rank or standardized score.

    Measured: 12 hours each day for 3 days

  4. Fiber-Normalized Flatus Frequency

    The participant's flatus frequency (events/day) normalized by self-reported dietary fiber intake (grams/day). Normalization will allow assessment of typical adult flatulence frequency in relation to fiber consumption.

    Measured: 12 hours each day for 3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2025
  2. Study start1 Dec 2025
  3. Primary completion5 Sep 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07134543
Sponsor's protocol ID
Human Flatus Atlas
Status last verified
Dec 2025
First submitted
14 Aug 2025
Last updated
23 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We plan to share de-identified, aggregate individual participant data limited to total enrollment numbers and demographic characteristics (e.g., age range, sex distribution, and other baseline variables) collected during the study. No other data, including outcome or clinical data, will be shared. Supporting Information The shared dataset will not contain any information that could directly or indirectly identify participants. Data will be available in aggregate format only, and will be provided upon reasonable request from qualified researchers for the purposes of scientific transparency and verification of study population characteristics.

Questions about this trial

What is this clinical trial studying?

An observational study of All Health Backgrounds to Determine a Baseline of Flatus Activity, run by University of Maryland, College Park at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Brantley Hall, PhD (5407978040, brantley@umd.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Microbiome Activity Index (time frame: 12 hours each day for 3 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in